Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2001
09/05/2001EP0637300B1 Antiproliferative quinazolines
09/05/2001CN1311785A Tetrahydroquinoline derivatives as glycine antagonists
09/05/2001CN1311780A Substituted 3-thiocarbamoylpyrazoles
09/05/2001CN1311779A Succinoylamino lactams as inhibitors and as A beta protein production
09/05/2001CN1311777A High affinity ligands for nociceptin receptor ORL-1
09/05/2001CN1311771A Benzamidine derivative
09/05/2001CN1311692A Farnesyl protein transferase inhibitors with i(IN VIVO) Radiosensitizing
09/05/2001CN1311679A Benzimidazole derivatives as modulators of IgE
09/05/2001CN1311677A Remedies or preventives for intractable epilepsy
09/05/2001CN1311675A Compounds having IgE affecting properties
09/05/2001CN1070490C 吲哚衍生物 Indole derivatives
09/05/2001CN1070489C Process for synthesis of substituted sulphoxides
09/05/2001CN1070488C Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
09/04/2001USH1992 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their pharmaceutical uses
09/04/2001US6284785 1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives
09/04/2001US6284777 Carbohydrazide protease inhibitors
09/04/2001US6284774 4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
09/04/2001US6284768 Src family SH2 domain inhibitors
09/04/2001US6284767 Retroviral protease inhibiting compounds
09/04/2001US6284764 Antiproliferative agent
09/04/2001US6284758 Administering a pridazinone compound
09/04/2001US6284755 Inhibitors of prenyl-protein transferase
09/04/2001US6284710 Substituting 2-amino-4-alkylamino-1,3,5-triazine as herbicide
09/04/2001CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
08/2001
08/30/2001WO2001062946A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
08/30/2001WO2001062765A2 Small molecule modulators of g protein-coupled receptor six
08/30/2001WO2001062757A1 Novel compounds
08/30/2001WO2001062756A1 Pyridinylimidazoles
08/30/2001WO2001062751A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
08/30/2001WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
08/30/2001WO2001062738A1 Novel imidazoline compounds
08/30/2001WO2001062737A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
08/30/2001WO2001062736A1 Aryl fused azapolycyclic compounds
08/30/2001WO2001062734A1 Process for producing quinolonecarboxylic acids and intermediates thereof
08/30/2001WO2001062729A1 Novel compounds
08/30/2001WO2001062728A1 Novel compounds
08/30/2001WO2001062726A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/30/2001WO2001062705A2 Aminoalcohol derivatives
08/30/2001WO2001062301A2 Imaging agents for diagnosis of parkinson's disease
08/30/2001WO2001062248A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives
08/30/2001WO2001062234A2 Dosing regimen
08/30/2001WO2001062233A2 Adenosine receptor modulators
08/30/2001WO2001016272A3 Ligand and complex for catalytically bleaching a substrate
08/30/2001WO2001016261A3 Composition and method for bleaching a substrate
08/30/2001WO2000075119A3 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones used as herbicides
08/30/2001WO2000073269A3 Nicotine receptor ligands
08/30/2001WO2000071510A3 INHIBITORS OF FACTOR Xa
08/30/2001US20010018522 Neuropeptide y receptor ligand
08/30/2001US20010018521 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
08/30/2001US20010018445 Thalidomide
08/30/2001US20010018438 Nervous system disorders; psychological disorders
08/30/2001US20010018423 Anticoagulant agents
08/30/2001CA2401226A1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
08/30/2001CA2401036A1 Pyridinylimidazoles
08/30/2001CA2400953A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives
08/30/2001CA2400819A1 Method for producing quinolonecarboxylic acids and intermediates thereof
08/30/2001CA2400659A1 Novel imidazoline compounds
08/30/2001CA2400435A1 Novel compounds
08/30/2001CA2400434A1 Novel compounds
08/30/2001CA2400293A1 Novel compounds
08/30/2001CA2397669A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
08/30/2001CA2397558A1 Dosing regimen
08/30/2001CA2396971A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
08/30/2001CA2368447A1 Small molecule modulators of g protein-coupled receptor six
08/29/2001EP1127882A1 Tetrazole compounds as thyroid receptor ligands
08/29/2001EP1127878A1 3,4 - substituted pyrazoles for the treatment of inflammation
08/29/2001EP1127869A1 Novel compounds and medicinal use thereof
08/29/2001EP1127057A1 Naphthyridine compounds and thier azaisosteric analogues as antibacterials
08/29/2001EP1127052A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/29/2001EP1127051A2 Tricyclic pyrazole derivatives
08/29/2001EP1126854A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues
08/29/2001EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
08/29/2001EP1126846A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder
08/29/2001EP1126840A1 5ht(1) receptor agonists and metoclopramide for the treatment of migraine
08/29/2001EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
08/29/2001EP0831705B1 N-aryl-1,2,4-triazolin-5-ones
08/29/2001CN1310718A Heterocyclic compound as inhibitors of rotamase enzymes
08/29/2001CN1310709A N.N-substituted cyclic amine derivatives
08/29/2001CN1310706A Inhibitors of phospholipase enzymes
08/29/2001CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
08/29/2001CN1310702A Nitric ester and nitrate salts of specific drugs
08/29/2001CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions
08/29/2001CN1310621A Substituted anilide compounds and methods
08/29/2001CN1070192C Thiopyridine for use in control of helicobacter bacteria
08/29/2001CN1070191C Novel quinolone-or naphthyridonecarboxylic acid derivative or salt thereof
08/29/2001CN1070185C Process for producing N-substituted 3-hydroxypyrazoles compound
08/28/2001US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders
08/28/2001US6281359 Psychological disorders
08/28/2001US6281358 Process for the preparation of substituted pyrimidines
08/28/2001US6281356 Substituted pyrroles
08/28/2001US6281354 Analogs of duocarmycin and cc-1065
08/28/2001US6281352 Antiinflammatory agents
08/28/2001US6281338 Mono- and dipotassium salts of azo compounds
08/28/2001US6281243 Derivatives of azetidine and pyrrolidine
08/28/2001US6281231 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
08/28/2001US6281230 Isoindolines, method of use, and pharmaceutical compositions
08/28/2001US6281228 Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
08/28/2001US6281227 Inhibitors of the activity of factor xa.
08/28/2001US6281216 2-aminoquinoline derivatives having d4-agonistic activity
08/23/2001WO2001060826A2 SUCCINOYLAMINO CARBOCYCLES AND HETEROCYCLES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
1 ... 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 ... 1080